Curacle said Friday that it has signed a 2.3 trillion won ($1.97 billion) licensing and collaboration agreement with Thea Open Innovation to develop oral therapy CUE06-RE for diabetic macular edema and wet age-related macular degeneration.Under the accord, Thea Open Innovation, a sister company of T
Daewoong Pharmaceutical and Medytox have been continuing their domestic legal battles over the source of the botulinum toxin (BTX) strain for years.Industry officials are now paying attention to how the U.S. International Trade Commission (ITC)’s recent annulling of its final determination on the im
GC Pharma has again delayed confirming whether or not rumors about its manufacturing of Janssen’s Covid-19 vaccine were true.In a public filing on Thursday, GC Pharma said it made no specific decision regarding news reports on Aug. 28 about the possibility of producing Janssen’s vaccine.The latest a
The Supreme Court, on Thursday, dismissed the appeal filed by Novartis against Hanmi Pharmaceutical and Ahngook Pharmaceutical over the patent extension term of Galvus (ingredient: vildagliptin), closing the four-year-long patent dispute.The recent ruling marks the first case of domestic pharmaceuti
Hanmi Science said that it has entered a pandemic science alliance with the University of Oxford to conduct research to prevent new and mutated infectious diseases.“The pandemic, along with the basic vaccine supply problems in many countries, has brought us together,” Hanmi Science CEO Lim Jong-yoon
Dong-A ST received regulatory approval to conduct its third phase 1 clinical trial of donepezil transdermal patch for treating Alzheimer’s disease to check for optimum dose in long-term attachment.The phase 1b clinical trial of DA-5207, the company’s donepezil patch, is an additional study requested
Local pharmaceutical companies are obtaining the marketing approval for generic copies of Jardiance, an antidiabetic SGLT-2 inhibitor, one after another. The move is regarded as an early preparation to secure the Jardiance generic market when the patent of Jardiance expires in 2025.On Wednesday, the
Genencell said that the Ministry of Food and Drug Safety has approved the company’s investigational new drug (IND) application to conduct phase 2 and 3 clinical trials for ES16001, an oral Covid-19 treatment.Genencell explained that the ministry’s approval signals the official start of global clinic
Sotorasib and adagrasib are expected to compete with each other in the Kras G12C inhibitor market, which is regarded as a promising oncology field worldwide, industry officials said.Kras G12C is a mutation in multiple cancers, including lung, colorectal, and pancreatic cancers.On Tuesday, Novartis d
Viatris Korea will move out from the building of Pfizer Korea completely by the end of this year, and the two companies will reduce their workforce through voluntary retirement programs, according to industry officials.Pfizer Korea and Viatris Korea said they recently confirmed their plans to move t
GSK Korea said it has temporarily suspended the supply of eight GSK vaccines due to a misalignment in its technical documentation.The eight vaccines are Rotarix (rotavirus vaccine), Synflorix (pneumococcal vaccine), Menveo (meningococcal vaccine), Havrix (hepatitis A vaccine), Priorix (measles, mump
Huons Biopharma said Tuesday that it has signed an export contract with Haemato Pharm, a German-based pharmaceutical company, to exclusively supply Hutox, its botulinum toxin (BTX) product, to the European market.Under the accord, Huons Biopharma will supply its BTX product to Haemato Pharm for a de
Korean pharmaceutical and biotech companies said they would promote their latest pipelines and health technologies in Bio-Europe 2021, the largest biotech and healthcare event in Europe, from Oct. 25-28.As many countries, including Korea, have begun easing virus restrictions gradually, industry watc
The Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) selected Humedix to receive government support for facilities and machines to produce a Covid-19 vaccine.Humedix will get funding from the government to prepare equipment and facilities for producing a Rus
The Oxford University Innovation (OUI) Press Center said Hanmi Science CEO Lim Jong-yoon, the largest stakeholder of Cancer Rop, was appointed as a registered director of Oxford Vacmedix.Oxford Vacmedix, based at the Oxford Science Park, the U.K., is a biopharmaceutical firm spun out from the Univer
MDimune has agreed with China’s NeoCura Bio-Medical Technology (NeoCura), a company specializing in RNA therapeutics, to conduct collaborative studies of cell-derived vesicles (CDV)-based mRNA therapeutic cancer vaccines.Under the accord, the two companies will jointly seek opportunities of developi
Hanmi Pharmaceutical obtained approval for Esomezol Plus, a combination drug mixing a proton-pump inhibitor (PPI) with an antacid, heating the competition in the combo treatment market.On Friday, the Ministry of Food and Drug Safety granted the marketing license for Esomezol Plus Tab. 40/350mg as a
The mRNA vaccines against the Covid-19 pandemic have also shed light on the related technology as a next-generation vaccine for seasonal influenza. However, Korean companies remain cautious because of uncertain marketability, industry executives said Friday.Global pharmaceuticals, including Moderna,
Minority shareholders of biopharmaceutical companies, who had remained content with expressing simple discontent when problems arose, are beginning to change, according to industry executives.They form shareholder solidarity groups to call for managers to work out measures to bolster share prices an
Janssen’s Rybrevant (amivantamab), the first therapy for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, may obtain marketing approval in Korea, industry sources said.The Ministry of Food and Drug Safety is reviewing Janssen’s app